Brind.

Avantor and Medpace Financial Comparison Highlights Valuation Differences

Steady: 1 in the last 7 days Updated saturday

The latest in this situation

  1. Avantor reported that demand was performing well in the Americas, while Europe continued to lag behind.
  2. Avantor, a large-cap healthcare company, provides services in Europe, the Americas, and Africa.

How it started

1 report, 1 independent, last reported Oct 6. The briefing below covers this first event.

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Avantor, a large-cap healthcare company, is expanding its service reach into key global regions, including Europe, the Americas, and Africa. A comparison of Avantor and Medpace showed that 95.1% of Avantor shares are owned by institutional investors, compared to 78.0% for Medpace. Avantor has a beta of 0.94, indicating lower volatility than the S&P 500, while Medpace has a beta of 1.18.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The comparison of the two companies reveals differences in their financial profiles. Medpace has higher earnings than Avantor, despite having lower revenue. Avantor is currently trading at a lower price-to-earnings ratio than Medpace.

From dailypolitical.com

Who's involved

  • AvantorLarge-cap healthcare company providing services globally

How it developed

Newest first. Tap a step to see who reported it.
  1. Avantor reported that demand was performing well in the Americas, while Europe continued to lag behind.Sub-event
  2. Avantor is expanding its service reach into key global regions.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped